Your browser doesn't support javascript.
loading
TGFBR3L is associated with gonadotropin production in non-functioning gonadotroph pituitary neuroendocrine tumours.
Kolnes, Anders Jensen; Øystese, Kristin Astrid Berland; Sjöstedt, Evelina; Olarescu, Nicoleta Cristina; Heck, Ansgar; Pahnke, Jens; Dahlberg, Daniel; Berg-Johnsen, Jon; Ringstad, Geir; Casar-Borota, Olivera; Bollerslev, Jens; Jørgensen, Anders Palmstrøm.
Afiliação
  • Kolnes AJ; Department of Medical Biochemistry, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Sognsvannsveien 20, 0372, Oslo, Norway.
  • Øystese KAB; Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital, Oslo, Norway.
  • Sjöstedt E; Department of Medical Biochemistry, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Sognsvannsveien 20, 0372, Oslo, Norway. kroeys@ous-hf.no.
  • Olarescu NC; Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital, Oslo, Norway. kroeys@ous-hf.no.
  • Heck A; Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Pahnke J; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Dahlberg D; Department of Medical Biochemistry, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Sognsvannsveien 20, 0372, Oslo, Norway.
  • Berg-Johnsen J; Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital, Oslo, Norway.
  • Ringstad G; Department of Medical Biochemistry, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Sognsvannsveien 20, 0372, Oslo, Norway.
  • Casar-Borota O; Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital, Oslo, Norway.
  • Bollerslev J; Department of Pathology, Section of Neuropathology, University of Oslo and Oslo University Hospital, Oslo, Norway.
  • Jørgensen AP; Pahnke lab (Drug Discovery and Chemical Biology), Lübeck Institute of Dermatology, LIED, University of Lübeck, Lübeck, Germany.
Pituitary ; 26(2): 227-236, 2023 Apr.
Article em En | MEDLINE | ID: mdl-36952069
ABSTRACT

PURPOSE:

Transforming growth factor-beta receptor 3-like (TGFBR3L) is a pituitary enriched membrane protein selectively detected in gonadotroph cells. TGFBR3L is named after transforming growth factor-beta receptor 3 (TGFBR3), an inhibin A co-receptor in mice, due to sequence identity to the C-terminal region. We aimed to characterize TGFBR3L detection in a well-characterized, prospectively collected cohort of non-functioning pituitary neuroendocrine tumours (NF-PitNETs) and correlate it to clinical data.

METHODS:

144 patients operated for clinically NF-PitNETs were included. Clinical, radiological and biochemical data were recorded. Immunohistochemical (IHC) staining for FSHß and LHß was scored using the immunoreactive score (IRS), TGFBR3L and TGFBR3 were scored by the percentage of positive stained cells.

RESULTS:

TGFBR3L staining was selectively present in 52% of gonadotroph tumours. TGFBR3L was associated to IRS of LHß (median 2 [IQR 0-3] in TGFBR3L negative and median 6 [IQR 3-9] in TGFBR3L positive tumours, p < 0.001), but not to the IRS of FSHß (p = 0.32). The presence of TGFBR3L was negatively associated with plasma gonadotropin concentrations in males (P-FSH median 5.5 IU/L [IQR 2.9-9.6] and median 3.0 [IQR 1.8-5.6] in TGFBR3L negative and positive tumours respectively, p = 0.008) and P-LH (median 2.8 IU/L [IQR 1.9-3.7] and median 1.8 [IQR 1.1-3.0] in TGFBR3L negative and positive tumours respectively, p = 0.03). TGFBR3 stained positive in 22% (n = 25) of gonadotroph tumours with no correlation to TGFBR3L.

CONCLUSION:

TGFBR3L was selectively detected in half (52%) of gonadotroph NF-PitNETs. The association to LHß staining and plasma gonadotropins suggests that TGFBR3L may be involved in hormone production in gonadotroph NF-PitNETs.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Hipofisárias / Tumores Neuroendócrinos / Gonadotrofos Tipo de estudo: Risk_factors_studies Limite: Animals Idioma: En Revista: Pituitary Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Noruega

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Hipofisárias / Tumores Neuroendócrinos / Gonadotrofos Tipo de estudo: Risk_factors_studies Limite: Animals Idioma: En Revista: Pituitary Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Noruega